Literature DB >> 11433419

Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer.

L M Chen1, G B Hodge, L A Guarda, J L Welch, N M Greenberg, K X Chai.   

Abstract

BACKGROUND: Prostasin is a serine protease predominantly expressed in normal prostate epithelial cells. The biological function of prostasin has not been determined.
METHODS: Western blot and RT-PCR analyses were used to examine the expression of prostasin in prostate cancer cell lines. Immunohistochemistry was used to evaluate prostasin protein expression in human prostate cancer. An in vitro Matrigel invasion assay was used to test the invasiveness of prostate cancer cell lines forced to express recombinant prostasin.
RESULTS: Both prostasin protein and mRNA were found to be expressed in normal human prostate epithelial cells and a non-invasive human prostate cancer cell line, the LNCaP, but neither was found in invasive human prostate cancer cell lines DU-145 and PC-3. Prostasin mRNA expression was absent in invasive prostate cancer cell lines of a transgenic mouse model. Immunohistochemistry analysis showed that prostasin protein expression is down-regulated in high-grade prostate cancer. Transfection of DU-145 and PC-3 cells with a full-length human prostasin cDNA restored prostasin expression and reduced the in vitro invasiveness by 68 and 42%, respectively.
CONCLUSIONS: Our data indicate that prostasin may be implicated in normal prostate biology and is able to suppress prostate cancer invasion in vitro.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11433419     DOI: 10.1002/pros.1085

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  28 in total

Review 1.  Regulation of renal sodium handling through the interaction between serine proteases and serine protease inhibitors.

Authors:  Kenichiro Kitamura; Kimio Tomita
Journal:  Clin Exp Nephrol       Date:  2010-06-11       Impact factor: 2.801

Review 2.  Extending the knowledge in histochemistry and cell biology.

Authors:  Wolfgang-Moritz Heupel; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2009-11-28       Impact factor: 4.304

3.  Expression of prostasin and protease nexin-1 in rhesus monkey (Macaca mulatta) endometrium and placenta during early pregnancy.

Authors:  Hai-Yan Lin; Heng Zhang; Qing Yang; Hong-Xing Wang; Hong-Mei Wang; Karl X Chai; Li-Mei Chen; Cheng Zhu
Journal:  J Histochem Cytochem       Date:  2006-06-26       Impact factor: 2.479

4.  An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex.

Authors:  Megha A Desai; Heather D Webb; Leander M Sinanan; J Neel Scarsdale; Ninad M Walavalkar; Gordon D Ginder; David C Williams
Journal:  Nucleic Acids Res       Date:  2015-03-09       Impact factor: 16.971

5.  Prostasin regulates epithelial monolayer function: cell-specific Gpld1-mediated secretion and functional role for GPI anchor.

Authors:  George M Verghese; Michael F Gutknecht; George H Caughey
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-05       Impact factor: 4.249

6.  The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy.

Authors:  Andrew S Murray; Thomas E Hyland; Kimberley E Sala-Hamrick; Jacob R Mackinder; Carly E Martin; Lauren M Tanabe; Fausto A Varela; Karin List
Journal:  Oncogene       Date:  2020-08-31       Impact factor: 9.867

7.  Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT).

Authors:  Li-Mei Chen; Nicole J Verity; Karl X Chai
Journal:  BMC Cancer       Date:  2009-10-22       Impact factor: 4.430

8.  Prostasin inhibits cell invasion in human choriocarcinomal JEG-3 cells.

Authors:  Xiao-jie Ma; Ya-yuan Fu; Yu-xia Li; Li-mei Chen; Karl Chai; Yan-ling Wang
Journal:  Histochem Cell Biol       Date:  2009-10-22       Impact factor: 4.304

9.  Prostasin, a potential tumor marker in ovarian cancer--a pilot study.

Authors:  Fernanda Pires Costa; Eraldo Luis Batista; Alice Zelmanowicz; Christer Svedman; Gabriela Devenz; Silvana Alves; Andrea Simões Martins da Silva; Bernardo Garicochea
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

10.  Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.

Authors:  Joanna Selzer-Plon; Jette Bornholdt; Stine Friis; Hanne C Bisgaard; Inger Mb Lothe; Kjell M Tveit; Elin H Kure; Ulla Vogel; Lotte K Vogel
Journal:  BMC Cancer       Date:  2009-06-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.